Cancer And Physical ACtivITY (CAPACITY) trial: A randomised control trial of exercise and self-management for people with lung cancer
- Conditions
- Lung cancerung cancerCancer - Lung - Non small cellPhysical Medicine / Rehabilitation - Physiotherapy
- Registration Number
- ACTRN12617001283369
- Lead Sponsor
- The University of Melbourne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 116
Adults, aged 18 years or over
-Able to provide consent
-Planned to receive surgical treatment for non-small cell lung cancer (NSCLC)
-Expected to be alive > 6 months
-Eastern Cooperate Oncology Group (ECOG) performance status of 0-2 at study entry
-Not currently meeting the physical activity guidelines (150 minutes of moderate intensity physical activity or 75 minutes of vigorous physical activity per week)
-Non-English speaking (insufficient English language skills to complete the questionnaires)
-Metastatic disease (stage IV lung cancer)
-Acute uncontrolled cardiovascular or respiratory issues
-Decompensated heart failure, severe aortic stenosis, uncontrolled arrhythmia, or acute coronary syndrome
-Non-ambulant (for example: amputee, spinal cord injury, wheel-chair bound)
-ECOG performance status of 3 or 4 at study entry
-Cognitive impairment (determined as not being able to provide consent for surgery)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Physical function measured by physical function domain of the European Organization for the Research and Treatment of Cancer Questionnaire (EORTC QLQ C30)[ The primary time point is 3 months post-operative. <br>This outcome is also measured at baseline (pre-operatively), and 6 and 12 months post-operative ]
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.